ADI-270: an armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies
Kevin Nishimoto, Blake T. Aftab(Unknown)
Cited by 11
Related Papers
No related papers found
Powered by citation graph analysis